Results 21 to 30 of about 1,396,067 (212)

Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain.

open access: yesNeuroscience Letters, 2007
Until recently the cannabinoid CB2 receptor was believed to be absent from the central nervous system. In this study we have identified CB2 expressing cells that appear in the rat brain following stroke and hypoxic-ischemia.
J. Ashton   +5 more
semanticscholar   +2 more sources

Structural basis of selective cannabinoid CB2 receptor activation

open access: yesNature Communications, 2023
Cannabinoid CB_2 receptor (CB_2R) agonists are investigated as therapeutic agents in the clinic. Here, authors report the discovery of LEI-102, a CB_2R agonist, used in conjunction with three other CBR ligands (APD371, HU308, and CP55,940) to investigate
Xiao-Ting Li   +18 more
semanticscholar   +1 more source

Cannabinoids for the control of experimental multiple sclerosis [PDF]

open access: yes, 2010
PhDThere have been numerous studies reporting that cannabinoids, both exogenous and endogenous, have a potential beneficial function during incidences of neurological damage.
Pryce, Gareth
core   +4 more sources

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential

open access: yesBiomedicines, 2022
Some of the most prevalent neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease, are proteinopathies characterized by the accumulation of specific protein aggregates in the brain.
Barbara Vuic   +7 more
semanticscholar   +1 more source

Cannabinoid CB(2) Receptor Activation Decreases Cerebral Infarction in a Mouse Focal Ischemia/Reperfusion Model.

open access: yesJournal of Cerebral Blood Flow and Metabolism, 2007
Jack Jallo   +2 more
exaly   +2 more sources

Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors. [PDF]

open access: yesPLoS ONE, 2016
Metabolic syndrome (MS) is a known risk factor for lower urinary tract symptoms. This study investigates whether functional and expression changes of cannabinoid CB1 and CB2 receptors are involved in the bladder dysfunction in an obese rat model with ...
Igor Blaha   +10 more
doaj   +1 more source

Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms

open access: yesCells, 2023
Cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) are components in the endocannabinoid system that play significant roles in regulating immune responses. There are many agonists for the cannabinoid receptors; however, their effects on T cell
Nuchjira Takheaw   +4 more
doaj   +1 more source

Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits

open access: yesFrontiers in Neuroscience, 2022
Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging evidence points to CB2 playing a key role in regulating neuronal function in the central nervous system.
Anthony S. Ferranti   +2 more
doaj   +1 more source

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966

open access: yesFrontiers in Pharmacology, 2022
Acutely, non-selective cannabinoid (CB) agonists have been shown to increase morphine antinociceptive effects, and we and others have also demonstrated that non-selective CB agonists attenuate morphine antinociceptive tolerance. Activation of cannabinoid
Zachary W. Reichenbach   +10 more
doaj   +1 more source

Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment. [PDF]

open access: yesPLoS ONE, 2016
We provide evidence for the presence of cannabinoid CB2 receptors in some cellular types of the cochlea of the adult albino rat. Cannabinoids and their receptors are increasingly being studied because of their high potential for clinical use.
Sergio Martín-Saldaña   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy